Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Journal of Acquired Immune Deficiency Syndromes
|
January 1, 1988
Projecting the medical costs of AIDS and ARC in the United States
J W Hay, D H Osmond, M A Jacobson
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 12, 1999
Cost-effectiveness analysis of alternative factor VIII products in treatment of haemophilia A
J W Hay, R L Ernst, C M Kessler
The American Journal of Cardiology
|
April 25, 1991
An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reduction
J W Hay, E H Wittels, A M Gotto
The American Journal of Cardiology
|
February 15, 1990
Medical costs of coronary artery disease in the United States
E H Wittels, J W Hay, A M Gotto
Health Care Financing Review
|
December 7, 1983
Physician pricing and health insurance reimbursement
D E Yett, W Der, R L Ernst, et al.
Health Care Financing Review
|
January 6, 1982
Blue Shield plan physician participation
D E Yett, W Der, R L Ernst, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 6, 2006
Commentary on Langley and McKenney Papers
T Ashraf, P C Langley, J W Hay, et al.
Archives of Neurology
|
June 1, 1997
Cognitive function and the costs of Alzheimer disease. An exploratory study
R L Ernst, J W Hay, C Fenn, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 6, 2006
From research into practice: how should healthcare organizations/governments decide about lipid therapy and who will pay? Reactor panel and open forum
P C Langley, J W Hay, J S Schwartz, et al.
Clinical Drug Investigation
|
May 18, 2007
Economic burden of haematological adverse effects in cancer patients: a systematic review
S Y Liou, J M Stephens, K T Carpiuc, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Journal of Acquired Immune Deficiency Syndromes
|
January 1, 1988
Projecting the medical costs of AIDS and ARC in the United States
J W Hay, D H Osmond, M A Jacobson
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 12, 1999
Cost-effectiveness analysis of alternative factor VIII products in treatment of haemophilia A
J W Hay, R L Ernst, C M Kessler
The American Journal of Cardiology
|
April 25, 1991
An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reduction
J W Hay, E H Wittels, A M Gotto
The American Journal of Cardiology
|
February 15, 1990
Medical costs of coronary artery disease in the United States
E H Wittels, J W Hay, A M Gotto
Health Care Financing Review
|
December 7, 1983
Physician pricing and health insurance reimbursement
D E Yett, W Der, R L Ernst, et al.
Health Care Financing Review
|
January 6, 1982
Blue Shield plan physician participation
D E Yett, W Der, R L Ernst, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 6, 2006
Commentary on Langley and McKenney Papers
T Ashraf, P C Langley, J W Hay, et al.
Archives of Neurology
|
June 1, 1997
Cognitive function and the costs of Alzheimer disease. An exploratory study
R L Ernst, J W Hay, C Fenn, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 6, 2006
From research into practice: how should healthcare organizations/governments decide about lipid therapy and who will pay? Reactor panel and open forum
P C Langley, J W Hay, J S Schwartz, et al.
Clinical Drug Investigation
|
May 18, 2007
Economic burden of haematological adverse effects in cancer patients: a systematic review
S Y Liou, J M Stephens, K T Carpiuc, et al.
Page
of 5